MichaelSujanSinhaMDJD, MPH

PubMed

• 2 citations
  Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018.
  Rachel E. Barenie, Michael S. Sinha, Aaron S. Kesselheim> ;Value in Health. 2021 Feb 1
• Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE.
  Avilash Cramer, Deborah Plana, Helen Yang, Mary M Carmack, Enze Tian, Michael S. Sinha, David Krikorian, David G. Turner, Jinhan Mo, Ju Li, Rajiv Gupta, Heather Mannin...> ;Scientific Reports. 2021 Jan 21
• Fentanyl panic goes viral: The spread of misinformation about overdose risk from casual contact with fentanyl in mainstream and social media
  Leo Beletsky, Sarah Seymour, Sunyou Kang, Zachary Siegel, Michael S. Sinha, Ryan Marino, Aashka Dave, Clark C. Freifeld> ;International Journal of Drug Policy. 2020 Dec 1
• Neither Ethical Nor Effective: The False Promise of Involuntary Commitment to Address the Overdose Crisis.
  Michael S. Sinha, John C. Messinger, Leo Beletsky> ;Journal of Law Medicine & Ethics. 2020 Dec 1
• Return to work during coronavirus disease 2019 (COVID-19): Temperature screening is no panacea.
  David H. Slade, Michael S. Sinha> ;Infection Control and Hospital Epidemiology. 2020 Sep 23
• 2 citations
  The Wrong Cure: Financial Incentives for Unimpressive New Antibiotics.
  Michael S. Sinha, John H. Powers, Aaron S. Kesselheim> ;The Journal of Infectious Diseases. 2020 Aug 22
• 1 citations
  Assessing the quality of nontraditional N95 filtering face-piece respirators available during the COVID-19 pandemic.
  Deborah Plana, Enze Tian, Avilash Cramer, Helen Yang, Mary M Carmack, Michael S. Sinha, Florence T. Bourgeois, Sherry H. Yu, Peter Masse, Jon Boyer, Minjune Kim, Jinha...> ;medRxiv. 2020 Jul 27
• Applying the Proportionality Principle to COVID-19 Antibody Testing
  Hrefna D. Gunnarsdóttir, Michael S. Sinha, Sara Gerke, Timo Minssen> ;Journal of Law and the Biosciences. 2020 Jul 25
• 3 citations
  Personal Protective Equipment for COVID-19: Distributed Fabrication and Additive Manufacturing.
  Michael S. Sinha, Florence T. Bourgeois, Peter K. Sorger> ;American Journal of Public Health. 2020 Jul 8
• 3 citations
  Regulatory and Safety Considerations in Deploying a Locally Fabricated, Reusable Face Shield in a Hospital Responding to the COVID-19 Pandemic.
  Arash Mostaghimi, Marc-Joseph Antonini, Deborah Plana, Philip D. Anderson, Brandon Beller, Edward W. Boyer, Amber Fannin, Jacob Freake, Richard Oakley, Michael S. Sinh...> ;medRxiv. 2020 Jun 19
• 1 citations
  Estimating The Cost Of Delayed Generic Drug Entry To Medicaid.
  Chintan V. Dave, Michael S. Sinha, Reed F. Beall, Aaron S. Kesselheim> ;Health Affairs. 2020 Jun 1
• 3 citations
  FDA and EMA Biosimilar Approvals
  Emily H. Jung, Ameet Sarpatwari, Aaron S. Kesselheim, Michael S. Sinha> ;Journal of General Internal Medicine. 2020 Jun 1
• 10 citations
  Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE: a quality improvement study.
  Avilash Cramer, Deborah Plana, Helen Yang, Mary M Carmack, Enze Tian, Michael S. Sinha, David Krikorian, David G. Turner, Jinhan Mo, Ju Li, Rajiv Gupta, Heather Mannin...> ;medRxiv. 2020 May 8
• 1 citations
  Rapid prototyping and clinical testing of a reusable face shield for health care workers responding to the COVID-19 pandemic.
  Arash Mostaghimi, Marc-Joseph Antonini, Deborah Plana, Philip D. Anderson, Brandon Beller, Edward W. Boyer, Amber Fannin, Jacob Freake, Richard Oakley, Michael S. Sinh...> ;medRxiv. 2020 Apr 15
• 82 citations
  Covid-19 - The Law and Limits of Quarantine.
  Wendy E. Parmet, Michael S. Sinha> ;The New England Journal of Medicine. 2020 Mar 18
• 2 citations
  What Does It Mean to Be a Male Ally? Implementing Meaningful Change in Gender Representation in Medicine
  Shikha Jain, Katayoun S. Madani, Lewis M. Flint, Mamta Swaroop, Howard Y. Liu, Thomas K. Varghese, Michael S. Sinha, Julie K. Silver> ;Journal of The American College of Surgeons. 2020 Jan 17
• Correction to: FDA and EMA Biosimilar Approvals.
  Emily H. Jung, Ameet Sarpatwari, Aaron S. Kesselheim, Michael S. Sinha> ;Journal of General Internal Medicine. 2019 Dec 5
• 1 citations
  Prescription Opioid Epidemic and Trends in the Clinical Development of New Pain Medications
  Thomas J. Hwang, Michael S. Sinha, Chintan V. Dave, Aaron S. Kesselheim> ;Mayo Clinic proceedings. 2019 Dec 1
• 4 citations
  Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem
  Aaron S. Kesselheim, Michael S. Sinha, Eric G. Campbell, Sebastian Schneeweiss, Paula Rausch, Brian M. Lappin, Esther H. Zhou, Jerry Avorn, Gerald J. Dal Pan> ;Drug Safety. 2019 Nov 1
• 2 citations
  Patients' Knowledge of Key Messaging in Drug Safety Communications for Zolpidem and Eszopiclone: A National Survey.
  Aaron S. Kesselheim, Michael S. Sinha, Paula Rausch, Zhigang Lu, Frazer A. Tessema, Brian M. Lappin, Esther H. Zhou, Gerald J. Dal Pan, Lee L. Zwanziger, Amy Ramanadha...> ;Journal of Law Medicine & Ethics. 2019 Sep 27
• Sexual Harassment in Medicine: Toward Legal Clarity and Institutional Accountability.
  Julie K. Silver, Michael S. Sinha> ;EClinicalMedicine. 2019 Jan 1
• 11 citations
  Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012
  Michael S. Sinha, Mehdi Najafzadeh, Elizabeth K. Rajasingh, James Love, Aaron S. Kesselheim> ;JAMA Internal Medicine. 2018 Nov 1
• The Tax Cuts and Jobs Act of 2017 and the Pharmaceutical Industry.
  Michael S. Sinha, Aaron S. Kesselheim> ;Journal of Law Medicine & Ethics. 2018 Oct 18
• 10 citations
  Micro-inequities in Medicine
  Julie K. Silver, Mary P. Rowe, Michael S. Sinha, Diana M. Molinares, Nancy D. Spector, Debjani Mukherjee> ;Pm&r. 2018 Oct 1
• 1 citations
  Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.
  Michael S. Sinha, Gregory D. Curfman, Michael A. Carrier> ;JAMA. 2018 Jun 12
• Join now to see all